Click for best price
SemiSolid Formulations Drug Delivery Market Size, Share 2022
The semi-solid drug category is comprised of creams, gels, ointments, suppositories, and other special topical dosage forms. Semi-solid drug formulations share many common attributes which include consistency, dosage uniformity, preservatives, the route of administration and their formulation basis.
This report contains market size and forecasts of Semi-Solid Formulations Drug Delivery in Global, including the following market information:
The global Semi-Solid Formulations Drug Delivery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Creams Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Semi-Solid Formulations Drug Delivery include Glenmark Pharmaceuticals, Galderma, Johnson & Johnson Private, GlaxoSmithKline, Bausch Health Companies, Hisamitsu Pharmaceuticals, Cipla, Bayer and Viatris, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Semi-Solid Formulations Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Semi-Solid Formulations Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Semi-Solid Formulations Drug Delivery Market Segment Percentages, by Type, 2021 (%)
- Creams
- Ointments
- Lotions
- Gel
- Pastes
Global Semi-Solid Formulations Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Semi-Solid Formulations Drug Delivery Market Segment Percentages, by Application, 2021 (%)
- Home Care Settings
- Hospitals & Clinics
- Burn Centers
- Other Facilities
Global Semi-Solid Formulations Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Semi-Solid Formulations Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Semi-Solid Formulations Drug Delivery revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Semi-Solid Formulations Drug Delivery revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Glenmark Pharmaceuticals
- Galderma
- Johnson & Johnson Private
- GlaxoSmithKline
- Bausch Health Companies
- Hisamitsu Pharmaceuticals
- Cipla
- Bayer
- Viatris
- 3M
- Merck & Co
- Crescita Therpeautics
- Novartis International
- Boehringer Ingelheim
- Pfizer
- Teva Pharmaceuticals
- Bristol Myers Squibb
- Lead Chemical
- Purdue Pharma
| Report Attributes |
Report Details |
| Report Title |
Semi-Solid Formulations Drug Delivery Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
106 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Semi-Solid Formulations Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Semi-Solid Formulations Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Semi-Solid Formulations Drug Delivery Overall Market Size
2.1 Global Semi-Solid Formulations Drug Delivery Market Size: 2021 VS 2028
2.2 Global Semi-Solid Formulations Drug Delivery Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Semi-Solid Formulations Drug Delivery Players in Global Market
3.2 Top Global Semi-Solid Formulations Drug Delivery Companies Ranked by Revenue
3.3 Global Semi-Solid Formulations Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Semi-Solid Formulations Drug Delivery Companies in Global Market, by Revenue in 2021
3.5 Global Companies Semi-Solid Formulations Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Semi-Solid Formulations Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Semi-Solid Formulations Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Semi-Solid Formulations Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Semi-Solid Formulations Drug Delivery Market Size Markets, 2021 & 2028
4.1.2 Creams
4.1.3 Ointments
4.1.4 Lotions
4.1.5 Gel
4.1.6 Pastes
4.2 By Type - Global Semi-Solid Formulations Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Semi-Solid Formulations Drug Delivery Revenue, 2017-2022
4.2.2 By Type - Global Semi-Solid Formulations Drug Delivery Revenue, 2023-2028
4.2.3 By Type - Global Semi-Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Semi-Solid Formulations Drug Delivery Market Size, 2021 & 2028
5.1.2 Home Care Settings
5.1.3 Hospitals & Clinics
5.1.4 Burn Centers
5.1.5 Other Facilities
5.2 By Application - Global Semi-Solid Formulations Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Semi-Solid Formulations Drug Delivery Revenue, 2017-2022
5.2.2 By Application - Global Semi-Solid Formulations Drug Delivery Revenue, 2023-2028
5.2.3 By Application - Global Semi-Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Semi-Solid Formulations Drug Delivery Market Size, 2021 & 2028
6.2 By Region - Global Semi-Solid Formulations Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Semi-Solid Formulations Drug Delivery Revenue, 2017-2022
6.2.2 By Region - Global Semi-Solid Formulations Drug Delivery Revenue, 2023-2028
6.2.3 By Region - Global Semi-Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Semi-Solid Formulations Drug Delivery Revenue, 2017-2028
6.3.2 US Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.3.3 Canada Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.3.4 Mexico Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Semi-Solid Formulations Drug Delivery Revenue, 2017-2028
6.4.2 Germany Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.4.3 France Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.4.4 U.K. Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.4.5 Italy Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.4.6 Russia Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.4.7 Nordic Countries Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.4.8 Benelux Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Semi-Solid Formulations Drug Delivery Revenue, 2017-2028
6.5.2 China Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.5.3 Japan Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.5.4 South Korea Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.5.5 Southeast Asia Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.5.6 India Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Semi-Solid Formulations Drug Delivery Revenue, 2017-2028
6.6.2 Brazil Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.6.3 Argentina Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Semi-Solid Formulations Drug Delivery Revenue, 2017-2028
6.7.2 Turkey Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.7.3 Israel Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.7.4 Saudi Arabia Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
6.7.5 UAE Semi-Solid Formulations Drug Delivery Market Size, 2017-2028
7 Players Profiles
7.1 Glenmark Pharmaceuticals
7.1.1 Glenmark Pharmaceuticals Corporate Summary
7.1.2 Glenmark Pharmaceuticals Business Overview
7.1.3 Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Major Product Offerings
7.1.4 Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.1.5 Glenmark Pharmaceuticals Key News
7.2 Galderma
7.2.1 Galderma Corporate Summary
7.2.2 Galderma Business Overview
7.2.3 Galderma Semi-Solid Formulations Drug Delivery Major Product Offerings
7.2.4 Galderma Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.2.5 Galderma Key News
7.3 Johnson & Johnson Private
7.3.1 Johnson & Johnson Private Corporate Summary
7.3.2 Johnson & Johnson Private Business Overview
7.3.3 Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Major Product Offerings
7.3.4 Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.3.5 Johnson & Johnson Private Key News
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Corporate Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Semi-Solid Formulations Drug Delivery Major Product Offerings
7.4.4 GlaxoSmithKline Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.4.5 GlaxoSmithKline Key News
7.5 Bausch Health Companies
7.5.1 Bausch Health Companies Corporate Summary
7.5.2 Bausch Health Companies Business Overview
7.5.3 Bausch Health Companies Semi-Solid Formulations Drug Delivery Major Product Offerings
7.5.4 Bausch Health Companies Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.5.5 Bausch Health Companies Key News
7.6 Hisamitsu Pharmaceuticals
7.6.1 Hisamitsu Pharmaceuticals Corporate Summary
7.6.2 Hisamitsu Pharmaceuticals Business Overview
7.6.3 Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Major Product Offerings
7.6.4 Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.6.5 Hisamitsu Pharmaceuticals Key News
7.7 Cipla
7.7.1 Cipla Corporate Summary
7.7.2 Cipla Business Overview
7.7.3 Cipla Semi-Solid Formulations Drug Delivery Major Product Offerings
7.7.4 Cipla Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.7.5 Cipla Key News
7.8 Bayer
7.8.1 Bayer Corporate Summary
7.8.2 Bayer Business Overview
7.8.3 Bayer Semi-Solid Formulations Drug Delivery Major Product Offerings
7.8.4 Bayer Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.8.5 Bayer Key News
7.9 Viatris
7.9.1 Viatris Corporate Summary
7.9.2 Viatris Business Overview
7.9.3 Viatris Semi-Solid Formulations Drug Delivery Major Product Offerings
7.9.4 Viatris Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.9.5 Viatris Key News
7.10 3M
7.10.1 3M Corporate Summary
7.10.2 3M Business Overview
7.10.3 3M Semi-Solid Formulations Drug Delivery Major Product Offerings
7.10.4 3M Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.10.5 3M Key News
7.11 Merck & Co
7.11.1 Merck & Co Corporate Summary
7.11.2 Merck & Co Business Overview
7.11.3 Merck & Co Semi-Solid Formulations Drug Delivery Major Product Offerings
7.11.4 Merck & Co Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.11.5 Merck & Co Key News
7.12 Crescita Therpeautics
7.12.1 Crescita Therpeautics Corporate Summary
7.12.2 Crescita Therpeautics Business Overview
7.12.3 Crescita Therpeautics Semi-Solid Formulations Drug Delivery Major Product Offerings
7.12.4 Crescita Therpeautics Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.12.5 Crescita Therpeautics Key News
7.13 Novartis International
7.13.1 Novartis International Corporate Summary
7.13.2 Novartis International Business Overview
7.13.3 Novartis International Semi-Solid Formulations Drug Delivery Major Product Offerings
7.13.4 Novartis International Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.13.5 Novartis International Key News
7.14 Boehringer Ingelheim
7.14.1 Boehringer Ingelheim Corporate Summary
7.14.2 Boehringer Ingelheim Business Overview
7.14.3 Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Major Product Offerings
7.14.4 Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.14.5 Boehringer Ingelheim Key News
7.15 Pfizer
7.15.1 Pfizer Corporate Summary
7.15.2 Pfizer Business Overview
7.15.3 Pfizer Semi-Solid Formulations Drug Delivery Major Product Offerings
7.15.4 Pfizer Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.15.5 Pfizer Key News
7.16 Teva Pharmaceuticals
7.16.1 Teva Pharmaceuticals Corporate Summary
7.16.2 Teva Pharmaceuticals Business Overview
7.16.3 Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Major Product Offerings
7.16.4 Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.16.5 Teva Pharmaceuticals Key News
7.17 Bristol Myers Squibb
7.17.1 Bristol Myers Squibb Corporate Summary
7.17.2 Bristol Myers Squibb Business Overview
7.17.3 Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Major Product Offerings
7.17.4 Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.17.5 Bristol Myers Squibb Key News
7.18 Lead Chemical
7.18.1 Lead Chemical Corporate Summary
7.18.2 Lead Chemical Business Overview
7.18.3 Lead Chemical Semi-Solid Formulations Drug Delivery Major Product Offerings
7.18.4 Lead Chemical Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.18.5 Lead Chemical Key News
7.19 Purdue Pharma
7.19.1 Purdue Pharma Corporate Summary
7.19.2 Purdue Pharma Business Overview
7.19.3 Purdue Pharma Semi-Solid Formulations Drug Delivery Major Product Offerings
7.19.4 Purdue Pharma Semi-Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
7.19.5 Purdue Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Semi-Solid Formulations Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Semi-Solid Formulations Drug Delivery Market Drivers in Global Market
Table 3. Semi-Solid Formulations Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Semi-Solid Formulations Drug Delivery in Global Market
Table 5. Top Semi-Solid Formulations Drug Delivery Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Semi-Solid Formulations Drug Delivery Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Semi-Solid Formulations Drug Delivery Revenue Share by Companies, 2017-2022
Table 8. Global Companies Semi-Solid Formulations Drug Delivery Product Type
Table 9. List of Global Tier 1 Semi-Solid Formulations Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Semi-Solid Formulations Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Semi-Solid Formulations Drug Delivery Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Semi-Solid Formulations Drug Delivery Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Semi-Solid Formulations Drug Delivery Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Semi-Solid Formulations Drug Delivery Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 30. Glenmark Pharmaceuticals Corporate Summary
Table 31. Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Product Offerings
Table 32. Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 33. Galderma Corporate Summary
Table 34. Galderma Semi-Solid Formulations Drug Delivery Product Offerings
Table 35. Galderma Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Private Corporate Summary
Table 37. Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Product Offerings
Table 38. Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline Corporate Summary
Table 40. GlaxoSmithKline Semi-Solid Formulations Drug Delivery Product Offerings
Table 41. GlaxoSmithKline Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 42. Bausch Health Companies Corporate Summary
Table 43. Bausch Health Companies Semi-Solid Formulations Drug Delivery Product Offerings
Table 44. Bausch Health Companies Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 45. Hisamitsu Pharmaceuticals Corporate Summary
Table 46. Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Product Offerings
Table 47. Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 48. Cipla Corporate Summary
Table 49. Cipla Semi-Solid Formulations Drug Delivery Product Offerings
Table 50. Cipla Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 51. Bayer Corporate Summary
Table 52. Bayer Semi-Solid Formulations Drug Delivery Product Offerings
Table 53. Bayer Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 54. Viatris Corporate Summary
Table 55. Viatris Semi-Solid Formulations Drug Delivery Product Offerings
Table 56. Viatris Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 57. 3M Corporate Summary
Table 58. 3M Semi-Solid Formulations Drug Delivery Product Offerings
Table 59. 3M Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 60. Merck & Co Corporate Summary
Table 61. Merck & Co Semi-Solid Formulations Drug Delivery Product Offerings
Table 62. Merck & Co Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 63. Crescita Therpeautics Corporate Summary
Table 64. Crescita Therpeautics Semi-Solid Formulations Drug Delivery Product Offerings
Table 65. Crescita Therpeautics Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 66. Novartis International Corporate Summary
Table 67. Novartis International Semi-Solid Formulations Drug Delivery Product Offerings
Table 68. Novartis International Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 69. Boehringer Ingelheim Corporate Summary
Table 70. Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Product Offerings
Table 71. Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 72. Pfizer Corporate Summary
Table 73. Pfizer Semi-Solid Formulations Drug Delivery Product Offerings
Table 74. Pfizer Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 75. Teva Pharmaceuticals Corporate Summary
Table 76. Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Product Offerings
Table 77. Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 78. Bristol Myers Squibb Corporate Summary
Table 79. Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Product Offerings
Table 80. Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 81. Lead Chemical Corporate Summary
Table 82. Lead Chemical Semi-Solid Formulations Drug Delivery Product Offerings
Table 83. Lead Chemical Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 84. Purdue Pharma Corporate Summary
Table 85. Purdue Pharma Semi-Solid Formulations Drug Delivery Product Offerings
Table 86. Purdue Pharma Semi-Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Semi-Solid Formulations Drug Delivery Segment by Type in 2021
Figure 2. Semi-Solid Formulations Drug Delivery Segment by Application in 2021
Figure 3. Global Semi-Solid Formulations Drug Delivery Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Semi-Solid Formulations Drug Delivery Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Semi-Solid Formulations Drug Delivery Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Semi-Solid Formulations Drug Delivery Revenue in 2021
Figure 8. By Type - Global Semi-Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
Figure 9. By Application - Global Semi-Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
Figure 10. By Region - Global Semi-Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
Figure 11. By Country - North America Semi-Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
Figure 12. US Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Semi-Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
Figure 16. Germany Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 17. France Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Semi-Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
Figure 24. China Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 28. India Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Semi-Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
Figure 30. Brazil Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Semi-Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
Figure 33. Turkey Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Semi-Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 37. Glenmark Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Galderma Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Private Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bausch Health Companies Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Hisamitsu Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Cipla Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bayer Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Viatris Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. 3M Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Merck & Co Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Crescita Therpeautics Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Novartis International Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Boehringer Ingelheim Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Pfizer Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Teva Pharmaceuticals Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Bristol Myers Squibb Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Lead Chemical Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Purdue Pharma Semi-Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
